Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

A Systematic Review and Qualitative Synthesis Resulting in a Typology of Elementary Classroom Movement Integration Interventions.

Vazou S, Webster CA, Stewart G, Candal P, Egan CA, Pennell A, Russ LB.

Sports Med Open. 2020 Jan 6;6(1):1. doi: 10.1186/s40798-019-0218-8. Review.

2.

High-Resolution In Vivo Fundus Angiography using a Nonadaptive Optics Imaging System.

Okada M, Heeren TFC, Mulholland PJ, Maloca PM, Cilkova M, Rocco V, Fruttiger M, Egan CA, Anderson RS, Tufail A.

Transl Vis Sci Technol. 2019 Jun 27;8(3):54. doi: 10.1167/tvst.8.3.54. eCollection 2019 May.

3.

Facilitators and Barriers to Movement Integration in Elementary Classrooms: A Systematic Review.

Michael RD, Webster CA, Egan CA, Nilges L, Brian A, Johnson R, Carson RL.

Res Q Exerc Sport. 2019 Jun;90(2):151-162. doi: 10.1080/02701367.2019.1571675. Epub 2019 Feb 22.

PMID:
30794089
4.

Estimating Retinal Sensitivity Using Optical Coherence Tomography With Deep-Learning Algorithms in Macular Telangiectasia Type 2.

Kihara Y, Heeren TFC, Lee CS, Wu Y, Xiao S, Tzaridis S, Holz FG, Charbel Issa P, Egan CA, Lee AY.

JAMA Netw Open. 2019 Feb 1;2(2):e188029. doi: 10.1001/jamanetworkopen.2018.8029.

5.

Evaluation of a classroom movement integration training delivered in a low socioeconomic school district.

Stewart G, Webster CA, Weaver RG, Stodden DF, Brian A, Egan CA, Michael RD, Sacko R, Patey M.

Eval Program Plann. 2019 Apr;73:187-194. doi: 10.1016/j.evalprogplan.2018.12.010. Epub 2019 Jan 8.

PMID:
30682534
6.

Systematically Observed Movement Integration in a Low Socioeconomic School District: A Cross-Sectional, Observational Study.

Stewart G, Webster CA, Brian A, Stodden D, Egan CA, Weaver RG.

Am J Health Promot. 2019 Jun;33(5):749-755. doi: 10.1177/0890117118819348. Epub 2018 Dec 18.

PMID:
30563355
7.

Case study of a health optimizing physical education-based comprehensive school physical activity program.

Egan CA, Webster CA, Stewart GL, Weaver RG, Russ LB, Brian A, Stodden DF.

Eval Program Plann. 2019 Feb;72:106-117. doi: 10.1016/j.evalprogplan.2018.10.006. Epub 2018 Oct 5.

PMID:
30326329
8.

United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services.

Denniston AK, Lee AY, Lee CS, Crabb DP, Bailey C, Lip PL, Taylor P, Pikoula M, Cook E, Akerele T, Antcliff R, Brand C, Chakravarthy U, Chavan R, Dhingra N, Downey L, Eleftheriadis H, Ghanchi F, Khan R, Kumar V, Lobo A, Lotery A, Menon G, Mukherjee R, Palmer H, Patra S, Paul B, Sim DA, Talks JS, Wilkinson E, Tufail A, Egan CA; UK DR EMR Users Group.

Br J Ophthalmol. 2019 Jun;103(6):837-843. doi: 10.1136/bjophthalmol-2018-312568. Epub 2018 Sep 29.

9.

Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2.

Müller S, Heeren TFC, Bonelli R, Fruttiger M, Charbel Issa P, Egan CA, Holz FG.

Br J Ophthalmol. 2019 Mar;103(3):398-403. doi: 10.1136/bjophthalmol-2017-311785. Epub 2018 Jun 1.

PMID:
29858186
10.

Two-year process evaluation of a pilot program to increase elementary children's physical activity during school.

Webster CA, Weaver RG, Egan CA, Brian A, Vazou S.

Eval Program Plann. 2018 Apr;67:200-206. doi: 10.1016/j.evalprogplan.2018.01.009. Epub 2018 Feb 2.

PMID:
29422421
11.

COMPARING FUNDUS FLUORESCEIN ANGIOGRAPHY AND SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE EVALUATION OF DIABETIC MACULAR PERFUSION.

La Mantia A, Kurt RA, Mejor S, Egan CA, Tufail A, Keane PA, Sim DA.

Retina. 2019 May;39(5):926-937. doi: 10.1097/IAE.0000000000002045.

PMID:
29346244
12.

Partnerships for Active Children in Elementary Schools (PACES): First year process evaluation.

Egan CA, Webster C, Weaver RG, Brian A, Stodden D, Russ L, Nesbitt D, Vazou S.

Eval Program Plann. 2018 Apr;67:61-69. doi: 10.1016/j.evalprogplan.2017.12.002. Epub 2017 Dec 6.

PMID:
29227866
13.

PERIPAPILLARY PACHYCHOROID SYNDROME.

Phasukkijwatana N, Freund KB, Dolz-Marco R, Al-Sheikh M, Keane PA, Egan CA, Randhawa S, Stewart JM, Liu Q, Hunyor AP, Kreiger A, Nagiel A, Lalane R, Rahimi M, Lee WK, Jampol LM, Sarraf D.

Retina. 2018 Sep;38(9):1652-1667. doi: 10.1097/IAE.0000000000001907.

14.

Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.

Lee AY, Butt T, Chew E, Agron E, Clemons TE, Egan CA, Lee CS, Tufail A; UK EMR AMD Research Group.

Br J Ophthalmol. 2018 Apr;102(4):465-472. doi: 10.1136/bjophthalmol-2017-310939. Epub 2017 Aug 23.

15.

MACULAR TELANGIECTASIA TYPE 2: Quantitative Analysis of a Novel Phenotype and Implications for the Pathobiology of the Disease.

Okada M, Egan CA, Heeren TFC, Tufail A, Fruttiger M, Maloca PM.

Retina. 2018 Jan;38 Suppl 1:S97-S104. doi: 10.1097/IAE.0000000000001812.

PMID:
28834952
16.

ELECTROPHYSIOLOGICAL CHARACTERIZATION OF MACULAR TELANGIECTASIA TYPE 2 AND STRUCTURE-FUNCTION CORRELATION.

Okada M, Robson AG, Egan CA, Sallo FB, Esposti SD, Heeren TFC, Fruttiger M, Holder GE.

Retina. 2018 Jan;38 Suppl 1:S33-S42. doi: 10.1097/IAE.0000000000001746.

PMID:
28654458
17.

EFFECT OF DARK ADAPTATION AND BLEACHING ON BLUE LIGHT REFLECTANCE IMAGING IN MACULAR TELANGIECTASIA TYPE 2.

Okada M, Heeren TFC, Egan CA, Rocco V, Bonelli R, Fruttiger M.

Retina. 2018 Jan;38 Suppl 1:S89-S96. doi: 10.1097/IAE.0000000000001754.

PMID:
28654457
18.

The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema.

Denniston AK, Chakravarthy U, Zhu H, Lee AY, Crabb DP, Tufail A, Bailey C, Akerele T, Al-Husainy S, Brand C, Downey L, Fitt A, Khan R, Kumar V, Lobo A, Mahmood S, Mandal K, Mckibbin M, Menon G, Natha S, Ong JM, Tsaloumas MD, Varma A, Wilkinson E, Johnston RL, Egan CA; UK DR EMR Users Group.

Br J Ophthalmol. 2017 Dec;101(12):1673-1678. doi: 10.1136/bjophthalmol-2016-309838. Epub 2017 May 9.

PMID:
28487377
19.

UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice.

Lee AY, Lee CS, Egan CA, Bailey C, Johnston RL, Natha S, Hamilton R, Khan R, Al-Husainy S, Brand C, Akerele T, Mckibbin M, Downey L, Tufail A.

Br J Ophthalmol. 2017 Dec;101(12):1683-1688. doi: 10.1136/bjophthalmol-2016-309818. Epub 2017 May 6.

20.

Genome-wide analyses identify common variants associated with macular telangiectasia type 2.

Scerri TS, Quaglieri A, Cai C, Zernant J, Matsunami N, Baird L, Scheppke L, Bonelli R, Yannuzzi LA, Friedlander M; MacTel Project Consortium, Egan CA, Fruttiger M, Leppert M, Allikmets R, Bahlo M.

Nat Genet. 2017 Apr;49(4):559-567. doi: 10.1038/ng.3799. Epub 2017 Feb 27.

PMID:
28250457
21.

Natural history and effect of therapeutic interventions on subretinal fluid causing foveal detachment in macular telangiectasia type 2.

Mehta H, Müller S, Egan CA, Degli Esposti S, Tufail A, Sim DA, Holz FG, Browning AC, Amoaku WM, Charbel Issa P, Gillies MC.

Br J Ophthalmol. 2017 Jul;101(7):955-959. doi: 10.1136/bjophthalmol-2016-309237. Epub 2016 Oct 28.

PMID:
27793821
22.

Evaluation of Nonperfused Retinal Vessels in Ischemic Retinopathy.

Powner MB, Sim DA, Zhu M, Nobre-Cardoso J, Jones R, Syed A, Chang AA, Keane PA, Tufail A, Egan CA, Fruttiger M.

Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):5031-5037. doi: 10.1167/iovs.16-20007.

PMID:
27661854
23.

Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss?

Negretti GS, Amin R, Webster L, Egan CA.

Eye (Lond). 2016 Jun;30(6):873-6. doi: 10.1038/eye.2016.56. Epub 2016 Apr 8.

24.

UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injections.

Madhusudhana KC, Lee AY, Keane PA, Chakravarthy U, Johnston RL, Egan CA, Sim D, Zarranz-Ventura J, Tufail A, McKibbin M; UK AMD EMR Study Group.

Br J Ophthalmol. 2016 Dec;100(12):1617-1622. doi: 10.1136/bjophthalmol-2015-308077. Epub 2016 Mar 30.

PMID:
27030276
25.

The Evaluation of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography.

Bradley PD, Sim DA, Keane PA, Cardoso J, Agrawal R, Tufail A, Egan CA.

Invest Ophthalmol Vis Sci. 2016 Feb;57(2):626-31. doi: 10.1167/iovs.15-18034.

PMID:
26903223
26.

Visual acuity loss in patients with age-related macular degeneration measured using a novel high-pass letter chart.

Shah N, Dakin SC, Dobinson S, Tufail A, Egan CA, Anderson RS.

Br J Ophthalmol. 2016 Oct;100(10):1346-52. doi: 10.1136/bjophthalmol-2015-307375. Epub 2016 Feb 4.

PMID:
26846435
27.

The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening.

Sim DA, Mitry D, Alexander P, Mapani A, Goverdhan S, Aslam T, Tufail A, Egan CA, Keane PA.

J Diabetes Sci Technol. 2016 Feb 1;10(2):308-17. doi: 10.1177/1932296816629983. Review.

28.

Optical coherence tomography angiography and indocyanine green angiography for corneal vascularisation.

Ang M, Cai Y, MacPhee B, Sim DA, Keane PA, Sng CC, Egan CA, Tufail A, Larkin DF, Wilkins MR.

Br J Ophthalmol. 2016 Nov;100(11):1557-1563. doi: 10.1136/bjophthalmol-2015-307706. Epub 2016 Jan 28.

PMID:
26823396
29.

Optical Coherence Tomography Features Of Active And Inactive Retinal Neovascularization In Proliferative Diabetic Retinopathy.

Vaz-Pereira S, Zarranz-Ventura J, Sim DA, Keane PA, Smith R, Egan CA, Tufail A.

Retina. 2016 Jun;36(6):1132-42. doi: 10.1097/IAE.0000000000000869.

PMID:
26630315
30.

A simple method for in vivo labelling of infiltrating leukocytes in the mouse retina using indocyanine green dye.

Sim DA, Chu CJ, Selvam S, Powner MB, Liyanage S, Copland DA, Keane PA, Tufail A, Egan CA, Bainbridge JW, Lee RW, Dick AD, Fruttiger M.

Dis Model Mech. 2015 Nov;8(11):1479-87. doi: 10.1242/dmm.019018. Epub 2015 Aug 20.

31.

En face optical coherence tomography angiography for corneal neovascularisation.

Ang M, Cai Y, Shahipasand S, Sim DA, Keane PA, Sng CC, Egan CA, Tufail A, Wilkins MR.

Br J Ophthalmol. 2016 May;100(5):616-21. doi: 10.1136/bjophthalmol-2015-307338. Epub 2015 Aug 26.

PMID:
26311064
32.

Optical Coherence Tomography Angiography for Anterior Segment Vasculature Imaging.

Ang M, Sim DA, Keane PA, Sng CC, Egan CA, Tufail A, Wilkins MR.

Ophthalmology. 2015 Sep;122(9):1740-7. doi: 10.1016/j.ophtha.2015.05.017. Epub 2015 Jun 16.

PMID:
26088621
33.

Web-based phenotyping for Tourette Syndrome: Reliability of common co-morbid diagnoses.

Darrow SM, Illmann C, Gauvin C, Osiecki L, Egan CA, Greenberg E, Eckfield M, Hirschtritt ME, Pauls DL, Batterson JR, Berlin CM, Malaty IA, Woods DW, Scharf JM, Mathews CA.

Psychiatry Res. 2015 Aug 30;228(3):816-25. doi: 10.1016/j.psychres.2015.05.017. Epub 2015 May 27.

34.

Structural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis.

Mehta H, Sim DA, Keane PA, Zarranz-Ventura J, Gallagher K, Egan CA, Westcott M, Lee RW, Tufail A, Pavesio CE.

Eye (Lond). 2015 Aug;29(8):1060-8. doi: 10.1038/eye.2015.65. Epub 2015 May 29.

35.

Automated retinal image analysis for diabetic retinopathy in telemedicine.

Sim DA, Keane PA, Tufail A, Egan CA, Aiello LP, Silva PS.

Curr Diab Rep. 2015 Mar;15(3):14. doi: 10.1007/s11892-015-0577-6. Review.

PMID:
25697773
36.

Diabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetes.

Liew G, Sim DA, Keane PA, Tan AG, Mitchell P, Wang JJ, Wong TY, Fruttiger M, Tufail A, Egan CA.

Acta Ophthalmol. 2015 Feb;93(1):e45-51. doi: 10.1111/aos.12519.

37.

Retinal vessel caliber changes in vasculitis.

Liew G, Tufail A, Cosatto VF, Tan AG, Zarranz-Ventura J, Sim DA, Kean PA, Egan CA, Mitchell P, Westcott MC, Lee RW, Pavesio CE.

Retina. 2015 Apr;35(4):803-8. doi: 10.1097/IAE.0000000000000369.

PMID:
25526098
38.

Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography.

Lee CS, Lee AY, Sim DA, Keane PA, Mehta H, Zarranz-Ventura J, Fruttiger M, Egan CA, Tufail A.

Am J Ophthalmol. 2015 Jan;159(1):101-10.e1. doi: 10.1016/j.ajo.2014.09.041. Epub 2014 Oct 25.

39.

Patterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-widefield fluorescein angiography.

Sim DA, Keane PA, Rajendram R, Karampelas M, Selvam S, Powner MB, Fruttiger M, Tufail A, Egan CA.

Am J Ophthalmol. 2014 Jul;158(1):144-153.e1. doi: 10.1016/j.ajo.2014.03.009. Epub 2014 Apr 4.

PMID:
24709807
40.

A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study).

Comyn O, Sivaprasad S, Peto T, Neveu MM, Holder GE, Xing W, Bunce CV, Patel PJ, Egan CA, Bainbridge JW, Hykin PG.

Am J Ophthalmol. 2014 May;157(5):960-70. doi: 10.1016/j.ajo.2014.02.019. Epub 2014 Feb 14.

PMID:
24531025
41.

A detailed phenotypic description of autosomal dominant cone dystrophy due to a de novo mutation in the GUCY2D gene.

Mukherjee R, Robson AG, Holder GE, Stockman A, Egan CA, Moore AT, Webster AR.

Eye (Lond). 2014 Apr;28(4):481-7. doi: 10.1038/eye.2014.7. Epub 2014 Jan 31.

42.

The extended clinical phenotype of dome-shaped macula.

Errera MH, Michaelides M, Keane PA, Restori M, Paques M, Moore AT, Yeoh J, Chan D, Egan CA, Patel PJ, Tufail A.

Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):499-508. doi: 10.1007/s00417-013-2561-7. Epub 2014 Jan 25.

PMID:
24464468
43.

Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant.

Heelan K, Ryan JF, Shear NH, Egan CA.

J Dermatol Case Rep. 2013 Dec 30;7(4):113-20. doi: 10.3315/jdcr.2013.1157. eCollection 2013.

44.

Quantitative analysis of diabetic macular ischemia using optical coherence tomography.

Sim DA, Keane PA, Fung S, Karampelas M, Sadda SR, Fruttiger M, Patel PJ, Tufail A, Egan CA.

Invest Ophthalmol Vis Sci. 2014 Jan 21;55(1):417-23. doi: 10.1167/iovs.13-12677.

PMID:
24398090
45.

Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function.

Fujinami K, Sergouniotis PI, Davidson AE, Wright G, Chana RK, Tsunoda K, Tsubota K, Egan CA, Robson AG, Moore AT, Holder GE, Michaelides M, Webster AR.

Am J Ophthalmol. 2013 Sep;156(3):487-501.e1. doi: 10.1016/j.ajo.2013.05.003.

PMID:
23953153
46.

Predictive factors for the progression of diabetic macular ischemia.

Sim DA, Keane PA, Zarranz-Ventura J, Bunce CV, Fruttiger M, Patel PJ, Tufail A, Egan CA.

Am J Ophthalmol. 2013 Oct;156(4):684-92. doi: 10.1016/j.ajo.2013.05.033. Epub 2013 Jul 24.

PMID:
23891332
47.

Repeatability and reproducibility of choroidal vessel layer measurements in diabetic retinopathy using enhanced depth optical coherence tomography.

Sim DA, Keane PA, Mehta H, Fung S, Zarranz-Ventura J, Fruttiger M, Patel PJ, Egan CA, Tufail A.

Invest Ophthalmol Vis Sci. 2013 Apr 23;54(4):2893-901. doi: 10.1167/iovs.12-11085.

PMID:
23538058
48.

The effects of macular ischemia on visual acuity in diabetic retinopathy.

Sim DA, Keane PA, Zarranz-Ventura J, Fung S, Powner MB, Platteau E, Bunce CV, Fruttiger M, Patel PJ, Tufail A, Egan CA.

Invest Ophthalmol Vis Sci. 2013 Mar 28;54(3):2353-60. doi: 10.1167/iovs.12-11103.

PMID:
23449720
49.

Effectiveness of a web-based protocol for the screening and phenotyping of individuals with Tourette syndrome for genetic studies.

Egan CA, Marakovitz SE, O'Rourke JA, Osiecki L, Illmann C, Barton L, McLaughlin E, Proujansky R, Royal J, Cowley H, Rangel-Lugo M, Pauls DL, Scharf JM, Mathews CA; Tourette Syndrome Association International Consortium for Genetics.

Am J Med Genet B Neuropsychiatr Genet. 2012 Dec;159B(8):987-96. doi: 10.1002/ajmg.b.32107. Epub 2012 Oct 22.

50.

Structural and functional changes over time in MacTel patients.

Schmitz-Valckenberg S, Ong EE, Rubin GS, Peto T, Tufail A, Egan CA, Bird AC, Fitzke FW.

Retina. 2009 Oct;29(9):1314-20. doi: 10.1097/IAE.0b013e3181a4d2f1.

PMID:
19491718

Supplemental Content

Support Center